SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Update

Icon doubles down on devices with new research group

CRO Icon has launched a new medical device and diagnostics research group following the combination of recently acquired Aptiv Solutions ’ expertise with its own experts.

Altasciences allies with nonclinical service org to offer more complete early development tools

Early phase clinical research service provider Altasciences is forming a strategic alliance with ITR Laboratories, a nonclinical services organization, to help more mutual clients customize their drug development programs from lead candidate selection to early stage trials. 

Quintiles looks to acquire new assets outside the US, CEO says

With operations already in more than 100 countries, the world’s largest CRO Quintiles is now looking to extend its global reach even farther, CEO Tom Pike told investors at the Barclays Global Healthcare Conference on Tuesday.

Patheon focuses on solubility with acquisition of Oregon-based CDMO

For the second time in just over a week, CDMO Patheon has made an acquisition, this time for Agere Pharmaceuticals, a privately held CDMO based in Bend, Oregon, that specializes in improving the bioavailability of drugs.

US FDA offers draft guidance on electronic informed consent

The draft guidance comes in the form of a Q&A and offers clinical investigators, IRBs and others a look into how electronic informed consent (eIC) should be done properly.

Spotlight

Researchers enthusiastic over Obama’s new $215m precision medicine initiative

Researchers enthusiastic over Obama’s new $215m precision medicine initiative

In what was largely a pep rally for science, President Obama on Friday unveiled his $215m precision...

Parexel sees book-to-bill bounce back as GSK strategic partnership renewal bears fruit

Parexel sees book-to-bill bounce back as GSK strategic partnership renewal bears fruit

One quarter after announcing a disappointing book-to-bill ratio, CRO Parexel has now renewed its strategic partnership with...

AstraZeneca turns to CRISPR for drug discovery; Are you watching Cellectis?

AstraZeneca turns to CRISPR for drug discovery; Are you watching Cellectis?

AstraZeneca has partnered to use the CRISPR genome editing technique across its discovery programmes in a move...

HCV drugs Sovaldi and Olysio boost Q1 sales for AmeriSourceBergen

HCV drugs Sovaldi and Olysio boost Q1 sales for AmeriSourceBergen

New hepatitis C drugs produced by Gilead, Janssen and AbbVie contributed to a first quarter spike in...

Strong USD to hit revenues but strategic CROs may see lower costs

Strong US Dollar to hit revenues but strategic CROs may see lower costs

The strengthening US Dollar will reduce CRO revenues, say analysts, but firms which have global strategic deals...

Biosimulation – the next step in PK modelling embraced by regulators

Biosimulation – the next step in PK modelling embraced by regulators

Computer-based drug modelling is moving from a discovery aid to a clinical tool accepted by regulators, according...